Susquehanna International Group, LLP Vanda Pharmaceuticals Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$4.61 - $6.34 $64,079 - $88,126	13,900 New	13,900 $65,000
Q1 2024 May 07, 2024	BUY	$3.47 - $4.61 $47,192 - $62,696	13,600 New	13,600 $55,000
Q4 2022 Feb 14, 2023	SELL	$6.87 - $10.96 $228,084 - $363,872	-33,200 Reduced 73.13%	12,200 $90,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $237,888 - $296,352	25,200 Added 124.75%	45,400 $449,000
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $122,892 - $156,288	-13,200 Reduced 39.52%	20,200 $220,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $2.39 Million - $3.65 Million	-220,700 Reduced 86.86%	33,400 $378,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $3.03 Million - $4.09 Million	193,400 Added 318.62%	254,100 $3.99 Million
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $46,050 - $63,810	3,000 Added 5.2%	60,700 $1.04 Million
Q2 2021 Aug 11, 2021	SELL	$15.71 - $21.51 $648,823 - $888,363	-41,300 Reduced 41.72%	57,700 $1.24 Million
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $872,300 - $1.32 Million	65,000 Added 191.18%	99,000 $1.49 Million
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $234,480 - $331,440	-24,000 Reduced 41.38%	34,000 $447,000
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $192,924 - $248,814	-20,700 Reduced 26.3%	58,000 $560,000
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $658,812 - $819,764	68,200 Added 649.52%	78,700 $900,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $171,750 - $384,720	-22,900 Reduced 68.56%	10,500 $109,000
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $133,704 - $188,676	10,800 Added 47.79%	33,400 $548,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $66,258 - $85,266	-5,400 Reduced 19.29%	22,600 $300,000
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $73,535 - $103,675	5,500 Added 24.44%	28,000 $395,000
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $33,421 - $58,995	1,900 Added 9.22%	22,500 $414,000
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $193,494 - $320,994	10,200 Added 98.08%	20,600 $538,000
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $133,225 - $167,900	-7,300 Reduced 41.24%	10,400 $239,000
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $51,615 - $70,855	3,700 Added 26.43%	17,700 $337,000
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $16,860 - $24,240	1,200 Added 9.38%	14,000 $236,000
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $300,690 - $423,540	-23,400 Reduced 64.64%	12,800 $195,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $557,480 - $682,370	36,200	36,200 $648,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$38 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$18.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$17 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$11 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$10.6 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account